Award for Research Careers in Hematology supports independent investigators conducting basic, translational, clinical, or outcomes-based blood research to make hematology research more accessible.
Funder: American Society of Hematology
Due Dates: November 2, 2026 (Applications available) | March 1, 2027 (Application deadline) | May 1, 2027 (Award notification)
Funding Amounts: $150,000 per award over 1, 2, or 3 years
Summary: Supports independent investigators conducting basic, translational, patient-oriented clinical, or outcomes-based research in hematology.
Key Information: Applicants must be ASH members and have $500,000 or less in other available resources, subject to stated exclusions.
The American Society of Hematology (ASH) runs ARCH to make hematology research more accessible to independent investigators. The program succeeds the ASH Bridge Grant, which was established in 2012 to sustain critical blood research amid severe National Institutes of Health funding restrictions. ARCH is an independent award, no longer tied to the NIH R01 funding mechanism, supporting basic, translational, patient-oriented clinical, and outcomes-based research.
ASH prioritizes at-risk communities within hematology, including researchers addressing health outcomes for populations with higher disease burdens and investigators with limited other funding opportunities. These priorities guide the Society’s use of limited resources while maintaining rigorous scientific review.